Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

NCT07143513 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT07143513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
August 11, 2025
Completion date
December 7, 2025
Enrollment
102 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer